Up­dat­ed: A short­age of amox­i­cillin is now be­ing re­port­ed by sev­er­al man­u­fac­tur­ers

On­ly a few weeks af­ter the FDA rec­og­nized a short­age of Adder­all, an­oth­er cru­cial drug is in low sup­ply, this time the an­tibi­ot­ic amox­i­cillin.

Ac­cord­ing to the Amer­i­can So­ci­ety of Health Sys­tem Phar­ma­cists’ (AH­SP) drug short­age list, three man­u­fac­tur­ers are post­ing short­ages of the oral ver­sion of the drug. The list in­cludes Hik­ma Phar­ma­ceu­ti­cals, Te­va and San­doz, which are re­port­ing low sup­plies of mul­ti­ple dosage amounts. The com­pa­nies did not post a rea­son for the short­ages.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER